horizontal_bar
/// Pipeline

The company is interested in licensing technologies across all disease areas and types of therapeutics—small molecules, antibodies, proteins, cell therapies, and nucleotides. BioMotiv seeks opportunities from lead optimization through IND-enabling stages of development; the company will also consider drug repurposing opportunities.

 

 

 

 

 


Click to view more

 

 

 

/// The Harrington Project

The Harrington Project for Discovery & Development is a $250 million US and UK initiative to support the discovery and development of therapeutic breakthroughs by physician-scientists.  It is a new and powerful national model that addresses a set of major challenges in advancing medicine.

  
      
 

Click to view more

 

 

horizontal_bar